164 related articles for article (PubMed ID: 10393715)
1. PSA as a treatment marker for prostate cancer?
Miller M
J Natl Cancer Inst; 1999 Jul; 91(13):1108-10. PubMed ID: 10393715
[No Abstract] [Full Text] [Related]
2. [From antigen to tumor marker. Results of research regarding PSA and its clinical applications].
De Angelis G; Brandt B; Schmid HP; Semjonow A
Urologe A; 2000 Jul; 39(4):309-12. PubMed ID: 10957771
[TBL] [Abstract][Full Text] [Related]
3. [Tumor marker in prostate cancer].
Arai Y
Nihon Hinyokika Gakkai Zasshi; 1994 Nov; 85(11):1575-92. PubMed ID: 7528825
[No Abstract] [Full Text] [Related]
4. Prostate cancer and prostate-specific antigen: the more we know, the less we understand.
Thompson I; Leach RJ; Pollock BH; Naylor SL
J Natl Cancer Inst; 2003 Jul; 95(14):1027-8. PubMed ID: 12865440
[No Abstract] [Full Text] [Related]
5. Re: an empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
Loeb S; Metter EJ; Carter HB
J Natl Cancer Inst; 2011 Nov; 103(21):1636-7; author reply 1637. PubMed ID: 21926375
[No Abstract] [Full Text] [Related]
6. Surrogate end points for prostate cancer: what is prostate-specific antigen telling us?
Sandler HM; DeSilvio ML
J Natl Cancer Inst; 2003 Sep; 95(18):1352-3. PubMed ID: 13130102
[No Abstract] [Full Text] [Related]
7. [Prostate-specific antigen for treatment monitoring].
Graefen M; Fröhner M; Wirth M
Urologe A; 2011 Mar; 50(3):309-12. PubMed ID: 21365346
[TBL] [Abstract][Full Text] [Related]
8. Current status of prostate cancer management in the prostate-specific antigen era.
Sartor O
Clin Prostate Cancer; 2004 Mar; 2(4):200-1. PubMed ID: 15072599
[No Abstract] [Full Text] [Related]
9. Words of wisdom. Re: PSA density improves prediction of prostate cancer.
Roobol MJ
Eur Urol; 2014 Nov; 66(5):964-5. PubMed ID: 25763443
[No Abstract] [Full Text] [Related]
10. PSA and the detection of prostate cancer.
Robbins AS
JAMA; 1994 Jan; 271(3):192-3. PubMed ID: 7506314
[No Abstract] [Full Text] [Related]
11. The prostate specific antigen. Its use as a tumor marker for prostate cancer.
Kantoff PW; Talcott JA
Hematol Oncol Clin North Am; 1994 Jun; 8(3):555-72. PubMed ID: 8707772
[TBL] [Abstract][Full Text] [Related]
12. [Active surveillance of low risk prostate cancer].
Weißbach L
Urologe A; 2015 Jun; 54(6):869-70. PubMed ID: 26081819
[No Abstract] [Full Text] [Related]
13. [The role of PSA in diagnosis of prostate cancer and its recurrence].
Vergho DC; Heine K; Wolff JM
Pathologe; 2005 Nov; 26(6):473-8. PubMed ID: 16215709
[TBL] [Abstract][Full Text] [Related]
14. [Prostate-specific antigen as a tumor marker of prostate carcinoma].
Wymenga LF; Mensink HJ
Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1733-8. PubMed ID: 10494319
[TBL] [Abstract][Full Text] [Related]
15. Re: Serum proteomic patterns for detection of prostate cancer.
Diamandis EP
J Natl Cancer Inst; 2003 Mar; 95(6):489-90; author reply 490-1. PubMed ID: 12644546
[No Abstract] [Full Text] [Related]
16. [Reply].
Lellig K; Buchner A; Stief C
Urologe A; 2015 Jun; 54(6):870. PubMed ID: 26280043
[No Abstract] [Full Text] [Related]
17. [Prostate cancer screening with a new marker based on circulating blood macrophages?].
Herwig R; Djavan B; Kramer G; El-Taieb MA; Kühhas F; Leers M; Marberger M
Urologe A; 2007 Sep; 46(9):1066-70. PubMed ID: 17622505
[No Abstract] [Full Text] [Related]
18. Prostate specific antigen through the years.
Kouriefs C; Sahoyl M; Grange P; Muir G
Arch Ital Urol Androl; 2009 Dec; 81(4):195-8. PubMed ID: 20608139
[TBL] [Abstract][Full Text] [Related]
19. [Prostate cancer screening: no proof of the benefit].
Laplanche A; Hill C
Presse Med; 2009 Oct; 38(10):1393-5. PubMed ID: 19647979
[No Abstract] [Full Text] [Related]
20. Role of prostate specific antigen (PSA) and carcinoembryonic antigen (CEA) in screening for prostate and recurrent colon cancers in the elderly.
Vandenberg TA
Clin Biochem; 1993 Dec; 26(6):429-30. PubMed ID: 7510220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
